The patient, her husband, the PA and I all welled up with tears as these images came up. This is before and after. Image on the left shows disease everywhere. The right side is what complete remission looks like.
#mmsm
@TischCancer
(*with permission from patient)
Just looked at my clinic list for tomorrow. 22 patients with myeloma. The youngest is 24 and the oldest is 90. Big F-U to cancer for impacting so many lives in so many ways so indiscriminately. We won’t stop until there is a 100% cure for 100% of people 100% of the time
Just told a patient that with our best technology we cannot measure his myeloma ….. Not only do i love saying that. But im saying more and more frequently …. To MRD and beyond!
#mmsm
I’m beyond touched to receive this from
@DarrenPanMD
He says that I always have myeloma on my mind. 😀. Looking forward to years of collaboration between
@UCSFCancer
and
@TischCancer
#mmsm
The husband of a patient is an artist who is doing a collection of drawings of the entire care team. Here’s his portrait of me. I won’t be offended if you don’t want to call me the Mona Lisa of Myeloma 😜.
#mmsm
@TischCancer
@NoopurRajeMD
making a passionate plea for the myeloma world to transition trials away from “lines of therapy” and more towards “drug exposure” An extremely important component of the path toward making all of the best drugs available to all patients!
#mmsm
Honored to be part of this. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
#mmsm
.
Best part about the patient summit with
@theMMRF
yesterday (besides working with a world class team and interacting with amazing patients) was having my daughter there. Here is her name tag. 🥹
#mmsm
@TischCancer
One of the best parts of my job is the honor of traveling to speak about
#myeloma
in other countries. My view from the bullet train en route to Nagoya . Learning and sharing medicine and culture globally is absolutely magical.
#mmsm
Up at 6am… home at 9pm… covering inpatient service with outpatient clinic (saw 32 myeloma patients today ).…. Kids asleep before I got home .. 2 more weeks of inpatient. Vacation after that.
@ABIMcert
@ABIMFoundation
suggests I work on MOC on vacation. Bye Felicia
Introducing Audrey Luna to the Twitter world. I typically post only about myeloma and medicine. But this is a reminder that the most important thing is family ☺️
The goal is cure ! Words to live by from Dr Sundar Jagannath who is being honored today the CFS meeting. An inspiration to all of us.
#mmsm
@TischCancer
@MountSinaiNYC
Honored to by co-lead author with Naresh Bumma on this amazing paper:
#msmm
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma | Journal of Clinical Oncology
Lessons learned from
#ASH21
1. In person meetings are amazing ! face to face is a necessity
2. We will be able to cure myeloma thanks to the amazing people working on this
3. Dr. Robert Kyle is a national treasure ! Could listen to him read the dictionary.
#mmsm
Good bye Greece. Thank you for an amazing
#IMS23
. Thank you to
@thanosdimop
for sharing your amazing city with us 😀. We laughed we learned we ate and drank. Can’t wait for more.
For those of you who don’t speak koala let me translate… “silly tourist. I wanna go back to sleep “. Had some amazing times discussing
#myeloma
in Australia!
@ninashah33
is simply the best. Just ask anyone who has ever worked for or with her. She is an amazing mentor and colleague! A true leader in the
#myeloma
world. And of course the leading
#myelebrity
.
#mmsm
#IMS23
Beyond honored to be working with giants of myeloma like
@Mohty_EBMT
and Thierry Facon
@COMyCongress
@PeerView
It’s been an amazing congress. Love talking shop with the international myeloma community
#mmsm
Thank you to my work family for the great birthday wishes. No I am not retiring. No I am not 70. Yes I do work with the greatest team of all time .
@TischCancer
#mmsm
Headed to Tokyo and then Nagoya for the JSTCT Annual Meeting: Japanese Society for Transplantation and Cellular Therapy. Talking about secondary immune deficiency in
#myeloma
.
#mmsm
I found this today while cleaning up my office. It’s a picture of our internal medicine residency at St. Vincent’s. I’m one of the interns in the back. Sometimes you only know how far you’ve come by taking a look back 😀
Grateful for PPE during this time. Thank you
@IcahnMountSinai
@MountSinaiNYC
. The light at the end of this tunnel comes faster and faster as we all work together
Just a friendly reminder that silliness is very important. In this complex and crazy world…. Stop for a moment and embrace being silly. Have a great weekend.
Getting ready to leave Japan. In all truth I feel I like I learned much more from the Japanese myeloma doctors than they did from me. The global community fighting
#myeloma
is awe inspiring !
#mmsm
1CyBorD. 3/2017
2VRD
3MEL200 ASCT
4Dara-IPd
5CAR-T
6XKd
7VDPACE
8Isatuximab+velcade+venetoclax+dex
9BEAM ASCT
10Belantamab+pom-dex. In remission. Since 3/22! Right patient, right time,right combo. Without bela this 50 y/o would have been on hospice
Another
#myeloma
approval today ! Elrexfio.
#mmsm
On August 14, 2023, the Food and Drug Administration granted accelerated approval to elranatamab-bcmm (Elrexfio, Pfizer, Inc.), a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager.
Treating multiple myeloma is like a chess game. You need to plan out several moves ahead. As such we sometimes need to ask insurance companies to approve more than one thing at a time. Attempting to channel the power of
@DGlaucomflecken
to fight these refusals.
Immense congratulations to a giant in the field of myeloma.
@myelomaMD
is this years winner of the Bart Barlogie award. He is an incredible asset to the myeloma world !
#IMS23
#mmsm
@Myeloma_Society
Amazing start to the meeting with
@Myeloma_Society
and
@US_FDA
! Awe inspiring words from
@VincentRK
advocating for the myeloma patients out there with truly unmet needs.
#mmsm
Beaming with pride and both humbled and honored to work with a true leader in every sense of the word. Always putting the patients first !!!! Congratulations to Dr Jagannath on winning the
#IMS23
Waldenstroms award.
#mmsm
@Myeloma_Society
@TischCancer
Headed to
#EHA2022
to present some amazing data on a bispecific antibody in myeloma. The field is exploding with innovation and I’m so thrilled to be a small part of it.
@EHA_Hematology
#mmsm
@TischCancer
Hanging with a great group of docs
@mbeksac56
Albert Orion and Paul Richardson. Ready to speak about relapsed and refractory myeloma
#mmsm
#EHA2024
U.S. FDA Approves TALVEY™ (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma..
#mmsm
I received this from a patient yesterday. She thanked me for “good deeds” (aka Mitzvahs). I love having this on my desk to remind me to be thankful to those who do good deeds to/for me and to remember to bestow good deeds upon others 😀
Up at 5 am for a 6am virtual lecture to some myeloma colleagues in Brazil. Shoutout to
@ldandersonjr
who gave a zoom lecture to Japanese colleagues at 2am last week. The fight to cure
#myeloma
never sleeps 😀
#mmsm
Having the site initiation visit (SIV) as we speak for the combination study of teclistamab and talquetamab. Very exciting early data for this combo especially in patients with extra medullary disease.
#mmsm
@TischCancer
I won’t lie. I have ascofomo
#ASCO24
. I’m missing good times with collaborators, new and interesting data. But the trade off is I caught up on work on Friday. This weekend I saw the Garfield movie with the kids and am having breakfast right now with my oldest. Balance
Today has been quite tough. Lots of very sick patients that I care deeply about. Having a moment for a good coffee and a good cry…..and then back to clinic for more
Early morning in Atlanta at the IMWG breakfast. So great to be in a room with the world’s brain trust focused on treating and curing myeloma
#mmsm
#ASH21
Such an important piece by
@MikkaelSekeres
. As cancer therapeutics and diagnostics advance all patients deserve second opinions. With telemedicine it’s easier than ever.
#mmsm
Extremely thought provoking data from Cassiopeia. Although not exactly congruent with US based treatment approaches, should patients now receive dara maintenance (along with revlimid) regardless of induction?
#mmsm
#myeloma
Putting together a section of a talk about the history of myeloma. Thinking of the title “see Kyle”. To anyone looking to begin to understand where we have come from in this disease. Go to pubmed.. type “Robert Kyle and Myeloma” and read !
#mmsm
@VincentRK
Thank you
@MetroPlusHealth
for denying a CART to a young myeloma patient because they are non secretory and you need an mspike to approve . Always appreciate an insurance company putting patients first !
#mmsm
Don’t worry we will continue to fight this!
Don’t get me wrong. I am a die hard New Yorker and I love my town. But there are few places more breathtaking than Tokyo Japan. Such an amazing city and people !
Just returned from an amazing trip to Japan. I’m still buzzing with the excitement of global collaboration! Continuing to work together to not only work towards a cure but to provide better quality of life until we find it!
#mmsm
@TischCancer
Blood cancer treatment: How multiple myeloma became nearly curable. We have a saying
@MountSinaiNYC
.. In Jagannath we trust !
#mmsm
@TischCancer
The holiday season is too often a very rough time for patients and caregivers alike. Old wounds and new wounds cut deep. Wishing patients and caregivers peace and warmth!
#mmsm
Honored today to be giving Medicine Grand Rounds at
@IcahnMountSinai
It’s still covid season so no podium in a hall... time for webcams and light rings !
@TischCancer
#mmsm
Just wanted to post something on the lighter side of things from
@theMMRF
Laugh for life from last year.
@HJChoMDPhD1
and I rocking out for a great cause
#mmsm
Thank you very much for submitting your manuscript.
Your paper was carefully reviewed. We regret to inform you that we will be unable to consider it for publication. Because of high submission rates, we can only publish a fraction of the papers received.
#MedTwitter